Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer
NCT04009941
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
104
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Neutropenia
Interventions
DRUG:
PEG-rhG-CSF
Sponsor
Peking University